News Business Export International
Christina Lake Cannabis announces entry into South African Market

(Globe Newswire) Vancouver — Christina Lake Cannabis Corp. has signed a Supply Agreement with MG BioTech Ventures (Pty) Limited, The Africann Group to supply custom formulations of medicinal cannabis oils into the South African medical cannabis market.

“Today marks a significant milestone in our revenue growth and product diversification strategy. As we have been focusing on strategic diversification opportunities for our high-quality cannabis products, we are pleased to announce this partnership with one of South Africa’s leading medical cannabis companies. Our goal is to combine our leading-edge technology with our expertise in formulation and cannabinoid customization, to create new value-added products for our customers. We believe that as the industry matures, we have a unique opportunity to provide turnkey product solutions that will allow our customers to optimize their business by leveraging our high-quality cannabis products.” — Mark Aiken, CEO, Christina Lake Cannabis

“We are extremely excited about our exclusive supply agreement with Christina Lake Cannabis. By accessing their best-of-breed technologies and formulations and as a result of their extremely economical production methodology, AfriCann will be able to provide South African patients with world-leading products at extremely cost-effective price points.” — Craig Ludwig, CCO, AfriCann

AfriCann is the first company to introduce legal access to life-changing cannabis medicines to South African patients on a national basis. Utilising existing medical regulations, the AfriCann group has built a scalable ecosystem to manage every aspect of the medical cannabis journey from patient education, doctor training & consultation, prescription & titration, distribution of trusted pharma-grade brands in multiple formats to at-home delivery countrywide. They have built an integrated cannabis ecosystem managing the entire doctor and patient journey.